Drug Shortage Report for CLINDAMYCIN INJECTION IN 5% DEXTROSE
| Report ID | 177050 |
| Drug Identification Number | 02485478 |
| Brand name | CLINDAMYCIN INJECTION IN 5% DEXTROSE |
| Common or Proper name | CLINDAMYCIN INJECTION IN 5% DEXTROSE |
| Company Name | BAXTER CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | CLINDAMYCIN |
| Strength(s) | 600MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 50mL |
| ATC code | J01FF |
| ATC description | MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2022-12-02 |
| Actual start date | 2022-12-02 |
| Estimated end date | 2022-12-12 |
| Actual end date | 2022-12-12 |
| Shortage status | Resolved |
| Updated date | 2022-12-12 |
| Company comments | Baxter products Clindamycin Injection in 5% Dextrose 300 mg / 50 mL (DIN : 02485451) & Clindamycin Injection in 5% Dextrose 900 mg / 50 mL (DIN : 02485486) are available as alternatives if they align with clinical practice. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2022-12-12 | French | Compare |
| v5 | 2022-12-12 | English | Compare |
| v4 | 2022-12-03 | English | Compare |
| v3 | 2022-12-02 | French | Compare |
| v2 | 2022-12-02 | English | Compare |
| v1 | 2022-12-02 | English | Compare |
Showing 1 to 6 of 6